Skip to main content
profilefund overviewpremium researchdividendsadv. chartsoptionsprice history

SPDR S&P BIOTECH ETF News

Biotechs Weakened by The Stock Market Rout

Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?

Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.

Biotech Stocks Could Rally

Valuations for biotech stocks have slumped, but could rebound.

Insiders Are Buying Biotech Stocks Again

Things may be looking up for biotech stocks, says Real Money's Bret Jensen.

Why Stocks Do Better After Getting Kicked Out of the Dow

Mark Hulbert explains why the most popular stocks often prove to be disappointing performers.

Breaking News

Crypto: 46,000 People Lost $1 Billion to Cons in 15 Months

Scammers are taking advantage of the crypto craze to line their pockets, FTC says.

American Nightmare: It Costs How Much More to Buy a Home?

Sky-high home prices are driving younger buyers out of the market.

Musk Endorses Fellow Billionaire in Los Angeles Mayoral Race

The CEO of Tesla has become one of the most influential voices in the world.

The Roblox Gaming Platform No Longer Sees Clearly

Roblox's shares are down 71% since January.